Manufacturer
Upsher-Smith Laboratories
- Products listed
- 184
- Molecules
- 65
- Therapy areas
- 15
Upsher-Smith Laboratories is a pharmaceutical manufacturer based in United States. MedsAcross lists 184 of its products across 65 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Upsher-Smith Laboratories, LLC, Upsher-Smith Laboratories, Inc., Upsher-Smith Laboratories, LLC, Upsher-Smith Laboratories,LLC, Upsher-Smith laboratories, LLC
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Upsher-Smith Laboratories products through licensed channels, with the documents your regulator needs.
Cardiology
35 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Diltiazem 300 mg extended-release capsuleOralGeneric name | Diltiazem | US FDA | Available on request |
| Diltiazem 360 mg extended-release capsuleOralGeneric name | Diltiazem | US FDA | Available on request |
| Diltiazem 60 mg extended-release capsuleOralGeneric name | Diltiazem | US FDA | Available on request |
| Diltiazem 90 mg extended-release capsuleOralGeneric name | Diltiazem | US FDA | Available on request |
| Doxazosin 1 mg tabletOralGeneric name | Doxazosin | US FDA | Available on request |
| Doxazosin 2 mg tabletOralGeneric name | Doxazosin | US FDA | Available on request |
| Doxazosin 4 mg tabletOralGeneric name | Doxazosin | US FDA | Available on request |
| Doxazosin 8 mg tabletOralGeneric name | Doxazosin | US FDA | Available on request |
| Ethacrynic acid 25 mg tabletOralGeneric name | Ethacrynic acid | US FDA | Available on request |
| Guanfacine 1 mg extended-release tabletOralGeneric name | Guanfacine | US FDA | Available on request |
| Guanfacine 2 mg extended-release tabletOralGeneric name | Guanfacine | US FDA | Available on request |
| Guanfacine 3 mg extended-release tabletOralGeneric name | Guanfacine | US FDA | Available on request |
| Guanfacine 4 mg extended-release tabletOralGeneric name | Guanfacine | US FDA | Available on request |
| Midodrine 10 mg tabletOralGeneric name | Midodrine | US FDA | Available on request |
| Midodrine 2.5 mg tabletOralGeneric name | Midodrine | US FDA | Available on request |
| Midodrine 5 mg tabletOralGeneric name | Midodrine | US FDA | Available on request |
| Nifedipine 30 mg extended-release tabletOralGeneric name | Nifedipine | US FDA | Available on request |
| Nifedipine 60 mg extended-release tabletOralGeneric name | Nifedipine | US FDA | Available on request |
| Nifedipine 90 mg extended-release tabletOralGeneric name | Nifedipine | US FDA | Available on request |
| Pacerone 100 mg tabletOral | Amiodarone | US FDA | Available on request |
| Pacerone 200 mg tabletOral | Amiodarone | US FDA | Available on request |
| Pacerone 400 mg tabletOral | Amiodarone | US FDA | Available on request |
| Pitavastatin 1 mg tabletOralGeneric name | Pitavastatin | US FDA | Available on request |
| Pitavastatin 2 mg tabletOralGeneric name | Pitavastatin | US FDA | Available on request |
| Pitavastatin 4 mg tabletOralGeneric name | Pitavastatin | US FDA | Available on request |
| Prevalite 4 g/5.5 g powder for oral suspensionOral | Cholestyramine | US FDA | Available on request |
| Tenormin 100 mg tabletOral | Atenolol | US FDA | Available on request |
| Tenormin 25 mg tabletOral | Atenolol | US FDA | Available on request |
| Tenormin 50 mg tabletOral | Atenolol | US FDA | Available on request |
| Zestril 10 mg tabletOral | Lisinopril | US FDA | Available on request |
| Zestril 2.5 mg tabletOral | Lisinopril | US FDA | Available on request |
| Zestril 20 mg tabletOral | Lisinopril | US FDA | Available on request |
| Zestril 30 mg tabletOral | Lisinopril | US FDA | Available on request |
| Zestril 40 mg tabletOral | Lisinopril | US FDA | Available on request |
| Zestril 5 mg tabletOral | Lisinopril | US FDA | Available on request |
Neurology
28 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Amantadine 100 mg tabletOralGeneric name | Amantadine | US FDA | Available on request |
| Amantadine 100 mg capsuleOralGeneric name | Amantadine | US FDA | Available on request |
| Bethanechol 10 mg tabletOralGeneric name | Bethanechol | US FDA | Available on request |
| Bethanechol 25 mg tabletOralGeneric name | Bethanechol | US FDA | Available on request |
| Bethanechol 5 mg tabletOralGeneric name | Bethanechol | US FDA | Available on request |
| Bethanechol 50 mg tabletOralGeneric name | Bethanechol | US FDA | Available on request |
| Carbamazepin 200 mg extended-release tabletOral | Carbamazepine | US FDA | Available on request |
| Carbamazepine 100 mg extended-release tabletOralGeneric name | Carbamazepine | US FDA | Available on request |
| Carbamazepine 400 mg extended-release tabletOralGeneric name | Carbamazepine | US FDA | Available on request |
| Divalproex 125 mg delayed-release tabletOralGeneric name | Divalproex | US FDA | Available on request |
| Divalproex 250 mg delayed-release tabletOralGeneric name | Divalproex | US FDA | Available on request |
| Divalproex 500 mg delayed-release tabletOralGeneric name | Divalproex | US FDA | Available on request |
| Qudexy XR 100 mg extended-release capsuleOral | Topiramate | US FDA | Available on request |
| Qudexy XR 150 mg extended-release capsuleOral | Topiramate | US FDA | Available on request |
| Qudexy XR 200 mg extended-release capsuleOral | Topiramate | US FDA | Available on request |
| Qudexy XR 25 mg extended-release capsuleOral | Topiramate | US FDA | Available on request |
| Qudexy XR 50 mg extended-release capsuleOral | Topiramate | US FDA | Available on request |
| Topiramate 100 mg extended-release capsuleOralGeneric name | Topiramate | US FDA | Available on request |
| Topiramate 15 mg capsuleOralGeneric name | Topiramate | US FDA | Available on request |
| Topiramate 150 mg extended-release capsuleOralGeneric name | Topiramate | US FDA | Available on request |
| Topiramate 200 mg extended-release capsuleOralGeneric name | Topiramate | US FDA | Available on request |
| Topiramate 25 mg extended-release capsuleOralGeneric name | Topiramate | US FDA | Available on request |
| Topiramate 25 mg capsuleOralGeneric name | Topiramate | US FDA | Available on request |
| Topiramate 50 mg extended-release capsuleOralGeneric name | Topiramate | US FDA | Available on request |
| Valproic acid 250 mg capsuleOralGeneric name | Valproic acid | US FDA | Available on request |
| Vigadrone 50 mg/mL powder for oral solutionOral | Vigabatrin | US FDA | Available on request |
| Vigadrone 500 mg tabletOral | Vigabatrin | US FDA | Available on request |
| Vigafyde 100 mg/mL oral solutionOral | Vigabatrin | US FDA | Available on request |
Psychiatry
27 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Bupropion 450 mg extended-release tabletOralGeneric name | Bupropion | US FDA | Available on request |
| Chlorpromazine 10 mg tabletOralGeneric name | Chlorpromazine | US FDA | Available on request |
| Chlorpromazine 100 mg tabletOralGeneric name | Chlorpromazine | US FDA | Available on request |
| Chlorpromazine 200 mg tabletOralGeneric name | Chlorpromazine | US FDA | Available on request |
| Chlorpromazine 25 mg tabletOralGeneric name | Chlorpromazine | US FDA | Available on request |
| Chlorpromazine 50 mg tabletOralGeneric name | Chlorpromazine | US FDA | Available on request |
| Clobazam 10 mg tabletOralGeneric name | Clobazam | US FDA | Available on request |
| Clobazam 20 mg tabletOralGeneric name | Clobazam | US FDA | Available on request |
| Donepezil 23 mg tabletOralGeneric name | Donepezil | US FDA | Available on request |
| Fluoxetine 20 mg/5 mL powder for oral solutionOralGeneric name | Fluoxetine | US FDA | Available on request |
| Fluphenazine 1 mg tabletOralGeneric name | Fluphenazine | US FDA | Available on request |
| Fluphenazine 10 mg tabletOralGeneric name | Fluphenazine | US FDA | Available on request |
| Fluphenazine 2.5 mg tabletOralGeneric name | Fluphenazine | US FDA | Available on request |
| Fluphenazine 5 mg tabletOralGeneric name | Fluphenazine | US FDA | Available on request |
| Fluvoxamine 100 mg extended-release capsuleOralGeneric name | Fluvoxamine | US FDA | Available on request |
| Fluvoxamine 150 mg extended-release capsuleOralGeneric name | Fluvoxamine | US FDA | Available on request |
| Forfivo XL 450 mg extended-release tabletOral | Bupropion | US FDA | Available on request |
| Galantamine 12 mg tabletOralGeneric name | Galantamine | US FDA | Available on request |
| Galantamine 4 mg tabletOralGeneric name | Galantamine | US FDA | Available on request |
| Galantamine 8 mg tabletOralGeneric name | Galantamine | US FDA | Available on request |
| Haloperidol 0.5 mg tabletOralGeneric name | Haloperidol | US FDA | Available on request |
| Haloperidol 1 mg tabletOralGeneric name | Haloperidol | US FDA | Available on request |
| Haloperidol 10 mg tabletOralGeneric name | Haloperidol | US FDA | Available on request |
| Haloperidol 2 mg tabletOralGeneric name | Haloperidol | US FDA | Available on request |
| Haloperidol 20 mg tabletOralGeneric name | Haloperidol | US FDA | Available on request |
| Haloperidol 5 mg tabletOralGeneric name | Haloperidol | US FDA | Available on request |
| Ramelteon 8 mg tabletOralGeneric name | Ramelteon | US FDA | Available on request |
Oncology
12 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Anastrozole 1 mg tabletOralGeneric name | Anastrozole | US FDA | Available on request |
| Bexarotene 75 mg capsuleOralGeneric name | Bexarotene | US FDA | Available on request |
| Exemestane 25 mg tabletOralGeneric name | Exemestane | US FDA | Available on request |
| Imatinib 100 mg tabletOralGeneric name | Imatinib | US FDA | Available on request |
| Imatinib 400 mg tabletOralGeneric name | Imatinib | US FDA | Available on request |
| Letrozole 2.5 mg tabletOralGeneric name | Letrozole | US FDA | Available on request |
| Megestrol 125 mg/mL oral suspensionOralGeneric name | Megestrol | US FDA | Available on request |
| Sorafenib 200 mg tabletOralGeneric name | Sorafenib | US FDA | Available on request |
| Torpenz 10 mg tabletOral | Everolimus | US FDA | Available on request |
| Torpenz 2.5 mg tabletOral | Everolimus | US FDA | Available on request |
| Torpenz 5 mg tabletOral | Everolimus | US FDA | Available on request |
| Torpenz 7.5 mg tabletOral | Everolimus | US FDA | Available on request |
Endocrinology
11 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Deflazacort 18 mg tabletOralGeneric name | Deflazacort | US FDA | Available on request |
| Deflazacort 30 mg tabletOralGeneric name | Deflazacort | US FDA | Available on request |
| Deflazacort 36 mg tabletOralGeneric name | Deflazacort | US FDA | Available on request |
| Deflazacort 6 mg tabletOralGeneric name | Deflazacort | US FDA | Available on request |
| Kymbee 18 mg tabletOral | Deflazacort | US FDA | Available on request |
| Kymbee 22.75 mg/mL oral suspensionOral | Deflazacort | US FDA | Available on request |
| Kymbee 30 mg tabletOral | Deflazacort | US FDA | Available on request |
| Kymbee 36 mg tabletOral | Deflazacort | US FDA | Available on request |
| Kymbee 6 mg tabletOral | Deflazacort | US FDA | Available on request |
| Methimazole 10 mg tabletOralGeneric name | Methimazole | US FDA | Available on request |
| Methimazole 5 mg tabletOralGeneric name | Methimazole | US FDA | Available on request |
Pain and anaesthesia
10 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Morphine 10 mg extended-release capsuleOralGeneric name | Morphine | US FDA | Available on request |
| Morphine 100 mg extended-release capsuleOralGeneric name | Morphine | US FDA | Available on request |
| Morphine 15 mg tabletOralGeneric name | Morphine | US FDA | Available on request |
| Morphine 20 mg extended-release capsuleOralGeneric name | Morphine | US FDA | Available on request |
| Morphine 30 mg tabletOralGeneric name | Morphine | US FDA | Available on request |
| Morphine 30 mg extended-release capsuleOralGeneric name | Morphine | US FDA | Available on request |
| Morphine 50 mg extended-release capsuleOralGeneric name | Morphine | US FDA | Available on request |
| Morphine 60 mg extended-release capsuleOralGeneric name | Morphine | US FDA | Available on request |
| Morphine 80 mg extended-release capsuleOralGeneric name | Morphine | US FDA | Available on request |
| Tosymra 10 mg/0.1 mL nasal sprayNasal | Sumatriptan | US FDA | Available on request |
Haematology
9 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Jantoven 1 mg tabletOral | Warfarin | US FDA | Available on request |
| Jantoven 10 mg tabletOral | Warfarin | US FDA | Available on request |
| Jantoven 2 mg tabletOral | Warfarin | US FDA | Available on request |
| Jantoven 2.5 mg tabletOral | Warfarin | US FDA | Available on request |
| Jantoven 3 mg tabletOral | Warfarin | US FDA | Available on request |
| Jantoven 4 mg tabletOral | Warfarin | US FDA | Available on request |
| Jantoven 5 mg tabletOral | Warfarin | US FDA | Available on request |
| Jantoven 6 mg tabletOral | Warfarin | US FDA | Available on request |
| Jantoven 7.5 mg tabletOral | Warfarin | US FDA | Available on request |
Gastroenterology
6 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Dexlansoprazole 30 mg delayed-release capsuleOralGeneric name | Dexlansoprazole | US FDA | Available on request |
| Dexlansoprazole 60 mg delayed-release capsuleOralGeneric name | Dexlansoprazole | US FDA | Available on request |
| Dicyclomine 10 mg capsuleOralGeneric name | Dicyclomine | US FDA | Available on request |
| Dicyclomine 20 mg tabletOralGeneric name | Dicyclomine | US FDA | Available on request |
| Famotidine 40 mg/5 mL powder for oral suspensionOralGeneric name | Famotidine | US FDA | Available on request |
| Mesalamine 0.375 g extended-release capsuleOralGeneric name | Mesalamine | US FDA | Available on request |
Dermatology
6 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Difluprednate 0.5 mg/mL ophthalmic emulsionOphthalmicGeneric name | Difluprednate | US FDA | Available on request |
| Isotretinoin 10 mg capsuleOralGeneric name | Isotretinoin | US FDA | Available on request |
| Isotretinoin 20 mg capsuleOralGeneric name | Isotretinoin | US FDA | Available on request |
| Isotretinoin 30 mg capsuleOralGeneric name | Isotretinoin | US FDA | Available on request |
| Isotretinoin 40 mg capsuleOralGeneric name | Isotretinoin | US FDA | Available on request |
| Nyamyc 100000 units/g topical powderTopical | Nystatin | US FDA | Available on request |
Rheumatology
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Naprelan 375 mg extended-release tabletOral | Naproxen | US FDA | Available on request |
| Naprelan 500 mg extended-release tabletOral | Naproxen | US FDA | Available on request |
| Naprelan 750 mg extended-release tabletOral | Naproxen | US FDA | Available on request |
| Naproxen 375 mg extended-release tabletOralGeneric name | Naproxen | US FDA | Available on request |
| Naproxen 500 mg extended-release tabletOralGeneric name | Naproxen | US FDA | Available on request |
Immunology and transplant
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Cyclosporine 0.5 mg/mL ophthalmic emulsionOphthalmicGeneric name | Cyclosporine | US FDA | Available on request |
| Dimethyl 120 mg delayed-release capsuleOralGeneric name | Dimethyl | US FDA | Available on request |
| Dimethyl 240 mg delayed-release capsuleOralGeneric name | Dimethyl | US FDA | Available on request |
Ophthalmology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Brimonidine 1 mg/mL eye dropsOphthalmicGeneric name | Brimonidine | US FDA | Available on request |
| Brimonidine 1.5 mg/mL eye dropsOphthalmicGeneric name | Brimonidine | US FDA | Available on request |
Antibiotics
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Moxifloxacin 5 mg/mL ophthalmic solutionOphthalmicGeneric name | Moxifloxacin | US FDA | Available on request |
| Vandazole 0.75% vaginal gelVaginal | Metronidazole | US FDA | Available on request |
Respiratory
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Terbutaline 2.5 mg tabletOralGeneric name | Terbutaline | US FDA | Available on request |
| Terbutaline 5 mg tabletOralGeneric name | Terbutaline | US FDA | Available on request |
Nephrology and urology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Oxybutynin 5 mg tabletOralGeneric name | Oxybutynin | US FDA | Available on request |
Other products
25 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Acetaminophen and Hydrocodone 325 mg/7.5 mg tabletOralGeneric name | Acetaminophen and Hydrocodone | US FDA | Available on request |
| Brimonidine and Timolol 2 mg/5 mg per mL eye dropsOphthalmicGeneric name | Brimonidine and Timolol | US FDA | Available on request |
| Ciprofloxacin and Dexamethasone 3 mg/1 mg per mL otic suspensionOticGeneric name | Ciprofloxacin and Dexamethasone | US FDA | Available on request |
| Cyclobenzaprine 15 mg extended-release capsuleOralGeneric name | Cyclobenzaprine | US FDA | Available on request |
| Cyclobenzaprine 30 mg extended-release capsuleOralGeneric name | Cyclobenzaprine | US FDA | Available on request |
| Glatiramer 20 mg/1 mL injectionSubcutaneous Cold chainGeneric name | Glatiramer | US FDA | Available on request |
| Glatiramer 40 mg/1 mL injectionSubcutaneous Cold chainGeneric name | Glatiramer | US FDA | Available on request |
| Klor-con 1.5 g powder for oral solutionOral | Potassium chloride | US FDA | Available on request |
| Klor-con 600 mg extended-release tabletOral | Potassium chloride | US FDA | Available on request |
| Klor-con 600 mg extended-release tabletOral | Potassium chloride | US FDA | Available on request |
| Klor-con 750 mg extended-release tabletOral | Potassium chloride | US FDA | Available on request |
| Klor-con 750 mg extended-release tabletOral | Potassium chloride | US FDA | Available on request |
| Klor-con M 1125 mg extended-release tabletOral | Potassium chloride | US FDA | Available on request |
| Klor-con M 1500 mg extended-release tabletOral | Potassium chloride | US FDA | Available on request |
| Klor-con M 750 mg extended-release tabletOral | Potassium chloride | US FDA | Available on request |
| Potassium chloride 1500 mg extended-release tabletOralGeneric name | Potassium chloride | US FDA | Available on request |
| Potassium chloride 600 mg extended-release tabletOralGeneric name | Potassium chloride | US FDA | Available on request |
| Potassium chloride 750 mg extended-release tabletOralGeneric name | Potassium chloride | US FDA | Available on request |
| Potassium citrate 10 mEq tabletOralGeneric name | Potassium citrate | US FDA | Available on request |
| Potassium citrate 5 mEq tabletOralGeneric name | Potassium citrate | US FDA | Available on request |
| Propafenone 425 mg extended-release capsuleOralGeneric name | Propafenone | US FDA | Available on request |
| Testosterone 1% gelTopicalGeneric name | Testosterone | US FDA | Available on request |
| Testosterone 12.5 mg gelTopicalGeneric name | Testosterone | US FDA | Available on request |
| Vogelxo 1% gelTopical | Testosterone | US FDA | Available on request |
| Vogelxo 12.5 mg gelTopical | Testosterone | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Upsher-Smith Laboratories
Send a request for any of these products. We confirm the licensed source, documents and lead time.